Esophageal Cancer Awareness Month: Updated guidance, treatment options, FDA news and more

Esophageal cancer is one of the deadliest forms of cancer with an estimated 19,260 diagnoses and 15,530 deaths in the United States last year, the American Association for Cancer Research reported.
Although 2021 brough forth both FDA and European Commission approvals for nivolumab with chemotherapy for treatment of gastric and esophageal cancers, regardless of PD-L1 expression status, and pembrolizumab with chemotherapy for HER2-negative advanced cancers, high disease burden remains.
The AACR reminds patients and providers of common signs and symptoms of esophageal cancer, including painful or

Esophageal cancer is one of the deadliest forms of cancer with an estimated 19,260 diagnoses and 15,530 deaths in the United States last year, the American Association for Cancer Research reported.
Although 2021 brough forth both FDA and European Commission approvals for nivolumab with chemotherapy for treatment of gastric and esophageal cancers, regardless of PD-L1 expression status, and pembrolizumab with chemotherapy for HER2-negative advanced cancers, high disease burden remains.
The AACR reminds patients and providers of common signs and symptoms of esophageal cancer, including painful or